Qun Lu Selected Research

Androgens

1/2020	Intratumor δ-catenin heterogeneity driven by genomic rearrangement dictates growth factor dependent prostate cancer progression.
1/2019	Inhibition of Cdc42-intersectin interaction by small molecule ZCL367 impedes cancer cell cycle progression, proliferation, migration, and tumor growth.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qun Lu Research Topics

Disease

52	Neoplasms (Cancer) 01/2024 - 04/2004
15	Prostatic Neoplasms (Prostate Cancer) 07/2022 - 10/2005
11	Carcinogenesis 07/2022 - 03/2009
10	Lung Neoplasms (Lung Cancer) 03/2019 - 10/2010
8	Inflammation (Inflammations) 01/2022 - 02/2012
7	Alzheimer Disease (Alzheimer's Disease) 01/2024 - 01/2008
6	Heart Failure 01/2023 - 07/2011
6	Urinary Bladder Neoplasms (Bladder Cancer) 01/2020 - 01/2015
6	Carcinoma (Carcinomatosis) 01/2020 - 05/2008
5	Neoplasm Metastasis (Metastasis) 05/2022 - 10/2010
4	Hyperglycemia 11/2023 - 01/2017
4	Insulin Resistance 11/2023 - 01/2018
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 08/2006
4	Type 2 Diabetes Mellitus (MODY) 10/2022 - 01/2020
4	Peripheral Nervous System Diseases (PNS Diseases) 01/2022 - 03/2010
4	ST Elevation Myocardial Infarction 10/2020 - 02/2015
4	Infections 01/2020 - 02/2008
4	Hypoxia (Hypoxemia) 01/2019 - 01/2013
4	Adenocarcinoma 11/2010 - 10/2005
3	Mental Disorders (Mental Disorder) 01/2024 - 01/2022
3	Multiple Sclerosis 11/2023 - 01/2021
3	Heart Diseases (Heart Disease) 01/2022 - 07/2013
3	Endometrial Neoplasms (Endometrial Cancer) 01/2022 - 12/2015
3	Atherosclerosis 01/2022 - 08/2006
3	Hypertrophy 01/2022 - 07/2014
3	Renal Cell Carcinoma (Grawitz Tumor) 03/2021 - 02/2017
3	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 06/2015
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023 - 01/2021
2	Neuroinflammatory Diseases 01/2022 - 01/2022
2	Endometrial Hyperplasia 01/2022 - 01/2021
2	Cardiomegaly (Heart Hypertrophy) 01/2022 - 02/2018
2	Spontaneous Abortion (Miscarriage) 01/2022 - 12/2021
2	Infarction (Infarctions) 01/2022 - 01/2019
2	Parkinson Disease (Parkinson's Disease) 01/2022 - 01/2021
2	Pathologic Processes 01/2022 - 01/2016
2	Rupture 01/2022 - 11/2020
2	Tobacco Use Disorder (Nicotine Dependence) 01/2021 - 05/2017
2	Overweight 01/2021 - 07/2011
2	Infertility (Sterility) 01/2021 - 12/2019
2	Human Influenza (Influenza) 12/2020 - 06/2017
2	Disease Progression 03/2020 - 01/2016
2	Cardiotoxicity 02/2020 - 01/2019
2	Fibrosis (Cirrhosis) 01/2019 - 01/2019
2	Testicular Neoplasms (Testicular Cancer) 11/2017 - 03/2009
2	Pain (Aches) 10/2017 - 10/2005
2	Hyperplasia 12/2015 - 05/2009

Drug/Important Bio-Agent (IBA)

22	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2005
10	Delta CateninIBA 10/2022 - 10/2005
10	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2012
9	CateninsIBA 10/2022 - 10/2005
7	ClaudinsIBA 03/2019 - 05/2009
6	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 01/2021 - 01/2009
6	Cisplatin (Platino)FDA LinkGeneric 01/2019 - 07/2008
5	Monomeric GTP-Binding ProteinsIBA 01/2024 - 01/2009
5	Proanthocyanidins (Procyanidins)IBA 11/2023 - 05/2018
5	Circular RNAIBA 07/2022 - 01/2019
5	MicroRNAs (MicroRNA)IBA 01/2022 - 10/2012
4	Glucose (Dextrose)FDA LinkGeneric 11/2023 - 01/2017
4	CytokinesIBA 01/2019 - 02/2012
4	Cadherins (E-Cadherin)IBA 07/2013 - 10/2005
3	ZCL278IBA 01/2024 - 01/2013
3	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2023 - 02/2018
3	Isoproterenol (Isoprenaline)FDA LinkGeneric 01/2023 - 02/2018
3	Neuroprotective AgentsIBA 01/2022 - 07/2008
3	Galectin 3 (LGALS3)IBA 01/2021 - 01/2019
3	Long Noncoding RNAIBA 02/2020 - 01/2017
3	Messenger RNA (mRNA)IBA 01/2018 - 09/2014
3	Indicators and Reagents (Reagents)IBA 10/2015 - 04/2004
3	Small Interfering RNA (siRNA)IBA 06/2015 - 03/2009
2	Carrier Proteins (Binding Protein)IBA 12/2023 - 01/2022
2	LigandsIBA 11/2023 - 12/2018
2	LipidsIBA 05/2023 - 09/2014
2	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 10/2022 - 01/2022
2	VaccinesIBA 10/2022 - 12/2020
2	Streptozocin (Streptozotocin)FDA Link 10/2022 - 01/2018
2	Therapeutic UsesIBA 01/2022 - 01/2019
2	Angiotensin IIIBA 01/2022 - 07/2014
2	procyanidinIBA 02/2021 - 05/2018
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2021 - 03/2011
2	Nicotine FDA Link 01/2021 - 05/2017
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020 - 08/2011
2	AndrogensIBA 01/2020 - 01/2019
2	Phosphotransferases (Kinase)IBA 01/2020 - 10/2009
2	IntegrinsIBA 03/2019 - 06/2015
2	rho-Associated KinasesIBA 01/2019 - 03/2010
2	Y 27632IBA 01/2019 - 03/2010
2	Antineoplastic Agents (Antineoplastics)IBA 01/2019 - 01/2014
2	Gemcitabine FDA Link 01/2017 - 01/2015
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 01/2013
2	Membrane Proteins (Integral Membrane Proteins)IBA 06/2015 - 08/2011
2	ligustilideIBA 07/2014 - 08/2006

Therapy/Procedure

20	Therapeutics 01/2024 - 04/2004
5	Nephrectomy 08/2023 - 02/2017
5	Drug Therapy (Chemotherapy) 07/2022 - 02/2008
3	Operative Time 08/2023 - 11/2018
3	Warm Ischemia 03/2021 - 02/2017
3	Renal Dialysis (Hemodialysis) 01/2021 - 01/2017
3	Percutaneous Coronary Intervention 06/2018 - 02/2015
2	Plasma Exchange 08/2023 - 11/2008
2	Patient Readmission 06/2018 - 02/2015